this is better than I thought; AccessBio will pay some break fee; and it is considered 'material'; for small companies 10% change in revenue or guidance is the material threshold; mind you, 10% on WHAT number; in any case, it is break fee so that is some monies coming in
the guarantee of antigen tests supply is good; also the new 'self test' antigen supply guarantee is good; but the financials we have no idea
Mr Market should like this announcement, I think
Ann: Atomo and Access Bio renegotiate supply agreements, page-7
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
